Robin Kendrick
Known title: DirectorCIK: 0001531378
Robin Kendrick's purchase track record
How the stock did after each of Robin Kendrick's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
3
of 3 since June 13, 2024
Stock higher 6 months later
33%
3 months: 67%
Median 6-month return
-9.2%
3 months: +9.6%
Beat the S&P 500
33%
median -7.9% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 12/12/2024 | PHIN | $4K | -23.3% | -16.9% | -0.1% |
| 9/12/2024 | PHIN | $4K | +18.3% | -9.2% | -1.3% |
| 6/13/2024 | PHIN | $4K | +9.6% | +29.7% | +11.4% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| PHIN | ▲ Buy | Grant | 33 | $0 | 9/18/2026 | View on chart |
| PHIN | ▲ Buy | Grant | 26 | $0 | 6/23/2026 | View on chart |
| PHIN | ▲ Buy | Grant | 2,140 | $0 | 5/22/2026 | View on chart |
| PHIN | ▲ Buy | Option Exercise | 4,724 | — | 5/21/2026 | View on chart |
| PHIN | ▲ Buy | Grant | 21 | $0 | 3/14/2025 | View on chart |
| PHIN | ▲ Buy | Grant | 16 | $0 | 12/13/2024 | View on chart |
| PHIN | ▲ Buy | Open Market | 74 | $4K | 12/12/2024 | View on chart |
| PHIN | ▲ Buy | Grant | 18 | $0 | 9/13/2024 | View on chart |
| PHIN | ▲ Buy | Open Market | 86 | $4K | 9/12/2024 | View on chart |
| PHIN | ▲ Buy | Grant | 20 | $0 | 6/14/2024 | View on chart |
| PHIN | ▲ Buy | Open Market | 94 | $4K | 6/13/2024 | View on chart |
| PHIN | ▲ Buy | Grant | 3,261 | $0 | 5/9/2024 | View on chart |
| PHIN | ▲ Buy | Grant | 90 | $0 | 3/15/2024 | View on chart |
| PHIN | ▲ Buy | Grant | 114 | $0 | 12/15/2023 | View on chart |
| PHIN | ▲ Buy | Grant | 125 | $0 | 9/22/2023 | View on chart |
| PHIN | ▲ Buy | Grant | 8,142 | $0 | 7/18/2023 | View on chart |
| PHIN | ▲ Buy | Grant | 4,749 | $0 | 7/18/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
UBS Lowers PHIN Target to $68, Keeps Neutral Rating
UBS has kept its neutral stance on Phinia Inc. and reduced its price target to $68. The new target sits below the stock’s recent support level of $78.33 and is lower than the average analyst target of $91.60. This adjustment reflects UBS’s more cautious outlook amid current market conditions.
UBS Lowers PHIN Target to $68, Keeps Neutral Rating. UBS has kept its neutral stance on Phinia Inc. and reduced its price target to $68. The new target sits below the stock’s recent support level of $78.33 and is lower than the average analyst target of $91.60. This adjustment reflects UBS’s more cautious outlook amid current market conditions.